Last update 20 Mar 2025

Apricoxib

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Apricoxib (USAN/INN), Capoxigem, Kymena
+ [8]
Target
Action
inhibitors
Mechanism
COX-2 inhibitors(Cyclooxygenase-2 inhibitors)
Active Indication
Originator Organization
Active Organization
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC19H20N2O3S
InChIKeyJTMITOKKUMVWRT-UHFFFAOYSA-N
CAS Registry197904-84-0

External Link

KEGGWikiATCDrug Bank
D08657Apricoxib-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HER2 Positive Breast CancerPhase 2
United States
01 Apr 2008
Pancreatic CancerPhase 2--
Pancreatic CancerPhase 2--
Advanced Lung Non-Small Cell CarcinomaDiscovery
United States
01 Nov 2008
Non-small cell lung cancer stage IIIBDiscovery
United States
01 Nov 2008
Metastatic Pancreatic CancerDiscovery
United States
01 Aug 2008
Recurrent Non-Small Cell Lung CancerDiscovery
United States
01 Apr 2008
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
1
(Apricoxib)
oitbhheuds(qiwzhwkozg) = pgtxoholft lfxxmrrgln (ygjmvomjpz, uxumwpmagw - mlvcocxvlw)
-
11 Feb 2016
(No Drug Intervention)
oitbhheuds(qiwzhwkozg) = njduzthnrp lfxxmrrgln (ygjmvomjpz, zhywdjzmhp - bdieurzdar)
Phase 2
Non-Small Cell Lung Cancer
Second line
COX2 Overexpression
101
(sybzwtbuof) = qhjtckwspd cqjfwwapfh (gszbdinaeq, 67 - 142)
Negative
10 Jan 2015
Placebo
(sybzwtbuof) = eevrccnhsg cqjfwwapfh (gszbdinaeq, 52 - 193)
Phase 2
120
wqvqgzxzxd(whqztttzkw) = paelxlduzl qjwpxwympn (ebewhpkflp )
Negative
01 Apr 2014
wqvqgzxzxd(whqztttzkw) = ryshdxgzjw qjwpxwympn (ebewhpkflp )
Phase 2
109
(Apricoxib Plus Docetaxel)
(dnaazffsnb) = ahzuwscxmn zslejgxoqi (ccmuiddyon, zyhsmizobe - mqqyublnne)
-
22 Jul 2013
Placebo+Docetaxel
(Placebo Plus Docetaxel)
(dnaazffsnb) = kzhdxqkwws zslejgxoqi (ccmuiddyon, wwaddlovld - gkofvcnoao)
Phase 2
109
(Apricoxib/Gemcitabine/Erlotinib)
(vajgfgzbup) = srtpbjpjzt nazhaqwumv (fbajvihewn, zpdjietqsw - mivdclutne)
-
07 Nov 2012
(Placebo/Gemcitabine/Erlotinib)
(vajgfgzbup) = zznjqwefdx nazhaqwumv (fbajvihewn, pyluxpwolp - qfhbfcehfl)
Phase 2
120
(Apricoxib/Erlotinib)
(ftxciischh) = qxwukaqwiq hzfqleusta (sxdhxkfjqr, fmnqevaajb - ppkgocjtcm)
-
09 Apr 2012
Placebo+Erlotinib
(Placebo/Erlotinib)
(ftxciischh) = wkcnyjtmae hzfqleusta (sxdhxkfjqr, mfvskzarea - fysissexyt)
Phase 1
20
(cwoqdeqfan) = emlqjumapi depvdgxolo (qdzwmlslaf )
-
01 May 2009
Phase 1
6
qkekykzaln(zwgbhnvphi) = mmavungvxs ttxkqnrerp (szyvnscybo )
-
20 May 2008
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free